Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

arthritis therapy

Known as: arthritis therapies, therapy arthritis 
National Institutes of Health

Related topics

Related topics

4 relations
Antirheumatic Agentsantiarthritic agentskeletal pharmacology

Broader (1)

Therapeutic procedure

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy.
Systemic delivery of siRNA to target tissues is difficult to achieve owing to its limited cellular uptake and poor serum… 
Review
2018
Review
2018
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
ABSTRACT Rheumatoid arthritis is a systemic autoimmune disease characterized by excess morbidity and mortality from… 
Highly Cited
2015
Highly Cited
2015
Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody
Rheumatoid arthritis therapies that are based on inhibition of a single cytokine, e.g., tumor necrosis factor α (TNFα) or… 
Review
2015
Review
2015
Whole-body MRI of juvenile spondyloarthritis: protocols and pictorial review of characteristic patterns
Spondyloarthritides are a group of inflammatory rheumatological diseases that cause arthritis with a predilection for spinal or… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Review
2014
Review
2014
Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy
Cytokines are the key mediators of inflammation in the course of autoimmune arthritis and other immune-mediated diseases… 
  • figure 1
  • table 1
  • figure 2
  • table 2
Highly Cited
2008
Highly Cited
2008
Glucocorticoid‐induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine‐induced COX‐2 expression
Cyclooxygenase‐2 (COX‐2) plays an important role in rheumatoid arthritis and therefore, has been a major target for anti… 
Review
2005
Review
2005
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis
Data from population- and clinic-based epidemiologic studies of rheumatoid arthritis patients suggest that individuals with… 
  • table 1
  • table 2
  • table 3
  • figure 1
Review
2003
Review
2003
Effectiveness of psoriatic arthritis therapies.
  • D. Gladman
  • Seminars in arthritis and rheumatism
  • 2003
  • Corpus ID: 21378589
OBJECTIVE To review the effectiveness of systemic therapies for psoriatic arthritis (PsA). METHODS Data on the efficacy of PsA… 
Review
2002
Review
2002
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors
Matrix metalloproteinase (MMP)-1, MMP-8 and MMP-13 are interstitial collagenases that degrade type II collagen in cartilage; this… 
  • figure 1
  • figure 2
Highly Cited
2001
Highly Cited
2001
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
BACKGROUND Patients with arthritis and vascular disease may receive both low-dose aspirin and other nonsteroidal antiinflammatory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE